Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb:174:169-174.
doi: 10.1016/j.ajo.2016.11.009. Epub 2016 Nov 23.

Gamma Knife Radiosurgery for Uveal Metastases: Report of Three Cases and a Review of the Literature

Affiliations
Review

Gamma Knife Radiosurgery for Uveal Metastases: Report of Three Cases and a Review of the Literature

William J Ares et al. Am J Ophthalmol. 2017 Feb.

Abstract

Purpose: Uveal metastases are ophthalmologic tumors that have historically been treated by fractionated external beam radiation therapy or invasive brachytherapy. The need for rapid response and less invasive management options led the authors to explore the use of Gamma Knife stereotactic radiosurgery (SRS) for this common problem.

Design: Interventional case series.

Methods: To prevent eye movement during the procedure, all 3 patients underwent a retrobulbar anesthetic block followed by magnetic resonance imaging to detect the target. All tumors were treated in a single procedure using the 4C or Perfexion Gamma Knife. The tumors received a minimal tumor dose of 14-20 Gy. Two patients also underwent SRS for additional intracranial metastases.

Results: At follow-up, performed between 4 and 15 months after SRS, all 3 patients demonstrated a reduction in uveal tumor volumes. One patient developed decreased visual acuity secondary to radiation retinopathy.

Conclusion: In this early experience, SRS was found to be an effective management option for uveal metastases associated with systemic cancer. Patients can be screened and treated effectively early after diagnosis using a joint approach between ophthalmologists and neurosurgeons. Systemic oncologic care can continue without interruption.

PubMed Disclaimer

Similar articles

Cited by

  • Clinical Characteristics and Management of Ocular Metastases.
    Gerba-Górecka K, Romanowska-Dixon B, Karska-Basta I, Cieplińska-Kechner E, Nowak MS. Gerba-Górecka K, et al. Cancers (Basel). 2025 Mar 20;17(6):1041. doi: 10.3390/cancers17061041. Cancers (Basel). 2025. PMID: 40149375 Free PMC article. Review.
  • The Economic Value of MR-Imaging for Uveal Melanoma.
    Grech Fonk L, Ferreira TA, Webb AG, Luyten GPM, Beenakker JM. Grech Fonk L, et al. Clin Ophthalmol. 2020 Apr 28;14:1135-1143. doi: 10.2147/OPTH.S238405. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32425499 Free PMC article.
  • How to Manage a Patient with Ocular Metastases?
    Thariat J, Boudin L, Loria O, Nguyen AM, Kodjikian L, Mathis T. Thariat J, et al. Biomedicines. 2022 Nov 25;10(12):3044. doi: 10.3390/biomedicines10123044. Biomedicines. 2022. PMID: 36551800 Free PMC article. Review.

LinkOut - more resources